KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

ClearPoint Neuro (CLPT) Total Non-Current Liabilities (2016 - 2026)

ClearPoint Neuro's Total Non-Current Liabilities history spans 10 years, with the latest figure at $69.2 million for Q4 2025.

On a quarterly basis, Total Non-Current Liabilities rose 401.72% to $69.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $69.2 million, a 401.72% increase, with the full-year FY2025 number at $69.2 million, up 401.72% from a year prior.
Total Non-Current Liabilities hit $69.2 million in Q4 2025 for ClearPoint Neuro, up from $44.2 million in the prior quarter.
Over the last five years, Total Non-Current Liabilities for CLPT hit a ceiling of $69.2 million in Q4 2025 and a floor of $13.8 million in Q4 2024.